Literature DB >> 23430685

The American Academy of Neurology's top five choosing wisely recommendations.

Annette M Langer-Gould1, Wayne E Anderson, Melissa J Armstrong, Adam B Cohen, Matthew A Eccher, Donald J Iverson, Sonja B Potrebic, Amanda Becker, Rod Larson, Alicia Gedan, Thomas S D Getchius, Gary S Gronseth.   

Abstract

OBJECTIVE: To discuss the American Academy of Neurology (AAN)'s Top Five Recommendations in the Choosing Wisely campaign promoting high-value neurologic medicine and physician-patient communication. The AAN published its Top Five Recommendations in February 2013 in collaboration with the American Board of Internal Medicine Foundation and Consumer Reports.
METHODS: A Choosing Wisely Working Group of 10 AAN members was formed to oversee the process and craft the evidence-based recommendations. AAN members were solicited for recommendations, the recommendations were sent out for external review, and the Working Group members (article authors) used a modified Delphi process to select their Top Five Recommendations. RESULTS AND RECOMMENDATIONS: The Working Group submitted 5 neurologic recommendations to the AAN Practice Committee and Board of Directors; all 5 were approved by both entities in September 2012. Recommendation 1: Don't perform EEGs for headaches. Recommendation 2: Don't perform imaging of the carotid arteries for simple syncope without other neurologic symptoms. Recommendation 3: Don't use opioids or butalbital for treatment of migraine, except as a last resort. Recommendation 4: Don't prescribe interferon-β or glatiramer acetate to patients with disability from progressive, nonrelapsing forms of multiple sclerosis. Recommendation 5: Don't recommend carotid endarterectomy for asymptomatic carotid stenosis unless the complication rate is low (<3%).

Entities:  

Mesh:

Year:  2013        PMID: 23430685     DOI: 10.1212/WNL.0b013e31828aab14

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Comparison of parenteral treatments of acute primary headache in a large academic emergency department cohort.

Authors:  Lucas H McCarthy; Robert P Cowan
Journal:  Cephalalgia       Date:  2014-11-03       Impact factor: 6.292

2.  Neurology Choosing Wisely recommendations: 74 and growing.

Authors:  Brian C Callaghan; Lindsey B De Lott; Kevin A Kerber; James F Burke; Lesli E Skolarus
Journal:  Neurol Clin Pract       Date:  2015-10

3.  How neurologists can choose (even more) wisely: prioritizing waste reduction targets and identifying gaps in knowledge.

Authors:  Brian C Callaghan; James F Burke; Eva L Feldman
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

4.  Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention.

Authors:  David E Jones
Journal:  Neurol Clin Pract       Date:  2013-12

5.  Disease-modifying therapies for nonrelapsing multiple sclerosis: Absence of evidence does not constitute evidence of absence.

Authors:  Jeffrey Dunn
Journal:  Neurol Clin Pract       Date:  2013-12

6.  Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999-2010.

Authors:  John N Mafi; Samuel T Edwards; Nigel P Pedersen; Roger B Davis; Ellen P McCarthy; Bruce E Landon
Journal:  J Gen Intern Med       Date:  2015-01-08       Impact factor: 5.128

Review 7.  Medical and Revascularization Therapies for Asymptomatic Carotid Stenosis.

Authors:  Sushrut Dharmadhikari; Seemant Chaturvedi
Journal:  Curr Atheroscler Rep       Date:  2015-08       Impact factor: 5.113

8.  Neurohospitalists and patient safety: lessons learned in 2013.

Authors:  Sumant R Ranji; Christopher Moriates
Journal:  Neurohospitalist       Date:  2014-04

Review 9.  Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.

Authors:  Jeffrey L Jackson; Josephine M Mancuso; Sarah Nickoloff; Rebecca Bernstein; Cynthia Kay
Journal:  J Gen Intern Med       Date:  2017-07-18       Impact factor: 5.128

Review 10.  Relapsing Painful Ophthalmoplegic Neuropathy: No longer a "Migraine," but Still a Headache.

Authors:  Stacy V Smith; Nathaniel M Schuster
Journal:  Curr Pain Headache Rep       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.